Detalles de la búsqueda
1.
Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience.
Mult Scler
; 26(7): 829-836, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968734
2.
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial.
Lancet
; 390(10089): 50-61, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526489
3.
A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Blood
; 118(24): 6299-305, 2011 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21960587
4.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine
; 62: 102109, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533419
5.
Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide.
Reprod Toxicol
; 95: 45-50, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32407881
6.
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study.
Mult Scler Relat Disord
; 46: 102438, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32911306
7.
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension studyâ â .
Mult Scler Relat Disord
; 33: 131-138, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195337
8.
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
Thyroid
; 24(4): 727-35, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24341527
9.
Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis.
Mult Scler Relat Disord
; 2(1): 60-3, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25877456
Resultados
1 -
9
de 9
1
Próxima >
>>